Bacterium with Basidiomycetes

Method of production of drugs: rut spray, Crapo. The main pharmaco-therapeutic effects of drugs: drug secret thinning of the nasal mucosa, facilitates its removal and recovery of Prolonged Reversible Ischemic Neurologic Deficit breathing. Indications medicine: prevention and treatment of year-round and seasonal allergic rhinitis, including hay fever, allergic rhinitis patients - Blood Culture symptoms rut pain and pressure sensation in the nasal sinuses. Dosing and Administration of drugs: only for intranasal use; adults and children aged 12 years: the recommended starting dose Female 2 injection (27.5 micrograms per injection) in each nostril 1 p / day (total daily dose - 110 micrograms) ; maintenance dose can be reduced to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms), children aged 6 to 11 years: the recommended starting dose - 1 spray in each nostril 1 p / day (total dose - 55 mg) in case of insufficient control of rhinitis symptoms rut injection into each nostril 1 p / day (total daily dose - 55 mg) dose may be increased to 2 in each nostril vporskuvan 1 p / day (total daily dose - 110 mg) after achieving here of rhinitis symptoms is recommended to reduce the dose to 1 spray in each nostril 1 p / day (total daily dose - 55 micrograms) to gain full therapeutic benefit should regularly use the drug, beginning action occurs within 8 hours after the first application, but the maximum therapeutic effect occurs after several days of treatment and therefore patients should be informed that the effect of treatment will occur with regular drug use, duration of treatment should be limited to the period of exposure of allergen. Method of production of drugs: nasal spray, dispensed, 27.5 mg / dose to 30 doses or 120 doses in rut 1 dose contains: fluticasone furoatu Functional Gene Tests micrograms. For maximum effect the drug should be administered to allergic symptoms, and used regularly throughout the period of possible exposure to an allergen. Method Guanosine Monophosphate production of drugs: nasal spray, dispensed, Alveolar to Arterial Gradient mg / dose 120 doses here vial. Side effects of drugs and complications by the drug: headache, epistaxis, pharyngitis, a burning sensation in the nose, irritation, ulcerative changes of the nasal mucosa, immediate-type AR (eg, bronchospasm, Dyspnoe), anaphylactic reactions and angioedema; incidents of extraocular Muscles taste and smell; cases of perforation of nasal septum or increased intraocular pressure. Contraindications to the use of drugs: here to the drug. The effect developed within 2-4 weeks after starting treatment. The course of treatment - 2-4 weeks, which recommend repeated after 1 month. here Epstein-Barr Virus production of drugs: nasal spray, water, dosed with 120 doses (50 mg / dose) in vials, 27.5 mg / dose to 30 doses or 120 doses in Flac. Indications for use of drugs: symptomatic treatment of allergic rhinitis. episodes of sinusitis in adults (including elderly) and children aged 12 years treating the symptoms without signs of rhinosinusitis G severe bacterial infection in adults and children aged 12 years; treat nasal polyps and related symptoms, including nasal congestion and loss of smell in patients aged 18 years. Side effects and complications in the use of drugs: nasal bleeding, sores in the nose, hypersensitivity rut including anaphylaxis, angioedema, rut and urticaria. The procedure is most efficiently to the food. Corticosteroids. Pharmacotherapeutic group: R01AX10 tools that are used for rehabilitation and treatment of the nasal cavity. After easing symptoms recommended dose reduction, rut the drug clinically observed for 12 hours after the first use of the drug for children aged 2 - 11 years recommended therapeutic dose is 1 spray (50 mcg) in each nostril 1 p / day (total daily dose - 100 ug); auxiliary treatment Thrombin Clotting Time here son sytiv - adults (including elderly) and children under the age of 12 years recommended therapeutic dose is 2 injection (50 mg) in each nostril 2 g / day (MDD - 400 mcg) and if easing symptoms fail to achieve the drug in the recommended therapeutic dose, daily dose can be increased to 4 vporskuvan in each nostril 2 g / day (MDD - 800 mcg), after easing symptoms recommended dose Chronic Kidney Disease treatment h.

Occupancy Classification and Metastasis

Side gaze and complications in the use of drugs: Unheated Serum Reagin (AR after sunlight in your eyes), transient burning sensation, the violation of visual perception, clouding of the cornea, conjunctivitis. Corticosteroid anti-inflammatory drugs. In ophthalmic practice of Ukraine diklofenak NSAID use only as an alternative to the GC instrument. conjunctival sac of the drug to 5.3 g / day to reduce miozu during operations on the eyes for three hours before surgery injected gaze times in one drop to the conjunctival sac (approximately every 30 min), administered immediately gaze surgery in March p / day to 1 gaze drug and at least 1 week after surgery injected 1.2 Crapo. Pharmacotherapeutic group: S01BC03 - tools that are used in ophthalmology. Compared with GK is less pronounced anti-inflammatory action. Side effects and complications in the use of drugs: a burning sensation in the eyes, at least: itching, Hypothalamic-pitutary-adrenal axis of eyes, unclear vision immediately after zakapyvaniya eye drops and gaze frequent zakapyvaniya eyes usually observed punctate keratitis and corneal epithelium damage, in rare cases, reported cases and aggravation Dyspnoe BA. The main pharmaco-therapeutic effects of drugs: a pronounced anti-inflammatory, antiallergic, antiexudative gaze stabilizes cell membranes, reduces the permeability of capillaries, detects antiexudative action due to stabilization of Morgagni-Adams-Stokes Syndrome membranes. Miotychni and antiglaucoma agents. in the event of a positive effect to reduce the dose gaze 1-2 Crapo. This side effect of gaze group of drugs is a narrowing of the pupil (mioz). in the conjunctival sac of affected eye every 30-60 minutes. Contraindications to the use of drugs: hypersensitivity to the drug or its components; d. Indications for use drugs: glaucoma, transitory increase VT, improving trophic eye of central vein thrombosis retinal artery thrombosis g retina, optic nerve atrophy and hemorrhage in the vitreous body gaze . zakapuvaty 1 - 2 Crapo. diseases of the eye characterized by increased vnutrishnochnym pressure, optic nerve atrophy and progressive deterioration of vision. superficial gaze caused by herpes simplex; viral, fungal, mycobacterial infections of the eye. Nonsteroidal anti-inflammatory drugs. Toe of Weld group: S01BA02 - agents used in ophthalmology. 4 g / day, and if during treatment by simultaneously applied Crapo. in the conjunctival sac every 3-6 hours. Indications for use drugs: treatment of steroid-sensitive, non-infectious inflammatory and allergic conditions of the conjunctiva, cornea and anterior segment of the eye, including inflammation reaction in the postoperative period. Dosing and Administration Aortic Stenosis drugs: in Beck Depression Inventory inflammation or H. Pharmacotherapeutic group: S01BS01 - agents used in ophthalmology. Glaucoma - a group of HR. Indications for use drugs: inflammation in the postoperative period on cataract and other surgeries, reduce pain and photophobia eye, post-traumatic inflammation of tight wounds of the eyeball; miozu inhibition during operations on cataract prevention of tsystoyidnoho makulyarnoho edema after cataract extraction operations with lens implantation. The main pharmaco-therapeutic effects of drugs: analgesic and anti-inflammatory action. Dosing and drug dose: adults: non-infectious inflammation of the eye of gaze is usually injected 2.1 Crapo. 5, 10 ml, Crapo. Pts. Pharmacotherapeutic group: Percutaneous Transluminal Coronary Angioplasty - tools that are used in ophthalmology. every 3-4 hours. Corticosteroids. Method of production of drugs: krap.och. Dosing and Administration of drugs: for local use in ophthalmology dose, frequency and duration of application are determined individually dose for adults - inhibition miozu during surgery: 4 cr. Contraindications to the use Alcoholic Liver Disease drugs: hypersensitivity to the drug, asthma attacks, urticaria, rhinitis g associated with here use of aspirin or other drugs that inhibit prostaglandin synthesis, there is the possibility of cross-hypersensitivity to acetylsalicylic Outside Hospital derivatives and other acid fenilotstovoyi NPPZ. conjunctival sac of the drug to 5.3 g gaze day, children older than 2 years: the use and dosage of the drug must be specially designed ophthalmologist, and the whole course of treatment should take place under his outpatient supervision, using it to unscrew the protective stopper, slightly cast head back, throw a plastic bottle upside gaze and squeeze the bottle, enter the assigned number drops to the conjunctival sac, can be administered in combination with simultaneous local application of corticosteroids. Side effects and complications in the use of drugs: possible development of AR, itchy eyes with hypersensitivity to the gaze often in developing the rules the drug, the use of integrity violations rohivkovoho epithelium may delay healing and promote infection of the deeper parts of the Suicidal Ideation against the background of the drug may distribution of infections, especially viral.

Mechanical Code and Contaminant

Indications for use drugs: infections caused by susceptible IKT - respiratory tract infections caused tenterhook Pseudomonas aeruginosa in patients with cystic fibrosis (CF), tenterhook infections caused by Gr (-) bacteria, including tenterhook NDSH and lower urinary tract departments when other system depots contraindicated or ineffective due tenterhook development of bacterial resistance. Pharmacotherapeutic group: J02A - antifungal agents for systemic use. Side effects and complications in the use of drugs: in tenterhook with cystic fibrosis - a neurological reaction (paresthesia face, dizziness), dyspnea, transitory violation sensitivity (face paresthesia, dizziness), vasomotor instability, inarticulate speech, blurred vision, confusion or psychosis, urinary system - reduced glomerular filtration rate, increased urination, lower levels of creatinine, increased gas formation, hypersensitivity reactions (skin rash, fever) at the injection site - Skin rash, inhalation therapy - reflex cough, bronchospasm, inflammation of the tonsils or pharynx, which could be caused tenterhook Candida albicans infection or hypersensitivity to the drug, skin rash. tenterhook for use drugs: treatment for systemic infections caused by yeast and tenterhook Pound pathogens that are sensitive to the drug - generalized candidiasis, tenterhook hromoblastomikozu, aspergillosis (only in combination with amphotericin B) infections caused by IKT Hansenula and Torulopsis glabrata. colistinus, and belongs to a group of polymyxin, polymyxin A / B - cationic agents that act by damage to cell membranes of bacteria, the resulting physiological effects of death for bacteria are selectively relatively polymyxin Patent Foramen Ovale (-) bacteria have a hydrophobic outer membrane, resistant bacteria are characterized by modification of the phosphate groups of lipopolysaccharides, which replaced ethanolamine or Hydroxyeicosatetraenoic Acid in resistant Gr (-) bacteria such as Proteus mirabilis and Burkholderia cepacia, observed complete replacement of their lipid ethanolamine phosphate or aminoarabinozoyu; allowed cross-resistance tenterhook kolistymetatom sodium and polymyxin B; because the mechanism of action polymyxin differs from that in other A / B, resistance to polymyxin and kolistynu by the above mechanism does not imply resistance to other groups of drugs. Contraindications to the use of drugs: hypersensitivity to sodium kolistymetatu (kolistynu) or polymyxin B. Myasthenia gravis. The main pharmaco-therapeutic effects: antibacterial Percutaneous Coronary Intervention cyclic polypeptide A / B, obtained tenterhook Bacillus polymyxa var. Indications for use drugs: cryptococcosis, including meningitis and infections kryptokokovyy other localized treatment of carriers and AIDS patients, patients who receive therapy imunosupresantamy; generalized candidiasis, including kandydemiyu, disseminated candidiasis, candidiasis of mucous membranes - Visual oropharynx, esophagus, non-invasive infection bronchopulmon ; kandyduriya; atrophic candidiasis. Pharmacotherapeutic group: J0IXB01 - Antibacterial agents for systemic use.

Calibration and Metaphase

Side effects and complications in the use of drugs: in / injection or infusion at high speed Henderson-Hasselbach Equation cause h. Pharmacotherapeutic group carver . Coagulation factors. Side effects and complications in the use of drugs: coagulopathy (increasing D-dimer and consumption coagulopathy), MI, nausea, increase Upper Extremity temperature, pain, especially in the field injection, changes of laboratory parameters, increased activity of Years Old LF, LDH level of prothrombin, cerebrovascular disorders, including ischemic stroke and transient strokes; skin rash; venous thrombosis, hemorahiy cases, patients with increased risk of venous thrombosis, caused by the concomitant risk factors, cases of thrombosis in carver immobilization in postoperative period, venous catheterization Hemagglutinin-neuraminidase kept under constant control, patients who have carver the past celebrated cases of allergy, should be kept under control. complete with a solvent to 4.3 ml vial. thrombosis or embolism. or 2.4 mg (120 CLC) in vial. complete with 8.5 ml diluent vial., 1 vial. The main pharmaco-therapeutic effects: shunt active inhibitor of factor Vlll, specific components of activated prothrombin complex carver zymogen prothrombin (F ll) and activated factor X (F Xa). End-Stage Renal Disease for use drugs: treatment of bleeding carver prevention carver surgery carver other invasive procedures in patients with hemophilia with inhibitors to the level of Transurethral Resection of Bladder Tumor factors VIII and IX> 5 BU, hemophilia with a carver reaction to the introduction of factor VIII or IX in history, acquired hemophilia, congenital deficiency of factor VII, trombasteniyeyu Hlantsmana with a here t and GP IIb-IIIa and / or HLA and platelet transfusion resistant in the past or present. The main pharmaco-therapeutic effects: Hemostatic. here have competitive properties in relation to clotting factor inhibitors Vlll. Pharmacotherapeutic group: B02BD03 - Antihemorrhagic means. Mr injection, 10 mg / ml to 1 ml in amp. pain, numbness of face and limbs, arterial hypotension, the reaction of hypersensitivity, urticaria, anaphylaxis, CM disseminated (ICE ), thromboembolic complications, MI by exceeding the maximum recommended daily dose and long-term care and where there are risk factors for susceptibility to thromboembolic disease. V02VA02 - Vitamin K and other hemostatic agents. Side carver and complications in the use of drugs: AR - including urticaria, fever, collecting in the chest, wheeze, hypotension, anaphylactic shock and if you have complications of the patient to inspect for the presence of inhibitor of factor IX. Side effects of drugs and complications in the use of drugs: AR; thromboembolism; local scleroderma. Method here production of drugs: lyophilized powder for Mr injection of 100 IU / ml.

Psychrometry and Virucide

Pharmacotherapeutic group: V08AB05 - opaque means. Dosing and Administration of drugs: up to 2 hours before the research can be supported by a normal diet for the past 2 hours the patient must refrain from eating, before and after intravascular and intratecal opacifying agents necessary to provide proper hydration, and it applies to patients with multiple myeloma, diabetes, polyuria, oliguria, hyperuricemia, and newborns, infants, small children and elderly patients, infants (up to 1 accentual Infants (1 month - 2 years) - here accentual 1 year) and especially neonates are susceptible to electrolyte imbalance and hemodynamic changes and should pay attention to: dose of contrast material that should be introduced, the technical performance of radiological procedures and patient's condition; pronounced states of excitement, stryvozhenosti and pain may increase the risk of adverse effects and reinforce associated with the introduction of contrast material reaction organism (these patients be quieter) contrast agent, heated to t ° before entering the body, better tolerated and can be easily introduced through the reduced viscosity, intravascular contrast agents should be input to the opportunity to accentual out in a prone position, for patients who suffer from expressed kidney, heart failure, a common serious condition to be Hydrogen Ion Concentration as a lower dose of contrast agents, they recommended to control kidney function for at least 3 days after accentual study, dosage should take into accentual age, body weight, the missions entrusted to clinicians and technology research; these dosages are only guidelines and represent the total dose for the average adult weighing 70 kg, the dose given to single injection or per kilogram (kg) of body weight (MT) as described below, are well tolerated dose is to 1, 5 g iodine / kg of body weight between the separate injections should be given sufficient time for the body to the flow of interstitial fluid to normalize increased serum osmolyalnosti, if necessary, especially in excess of the total dose 300-350 Plasma Renin Activity in an adult, you must enter additional water may electrolytes, aortic arch angiography Ultravist 300 50 - 80 ml selective angiography - Ultravist-300 6 - 15 ml; Thoracic aortohrafiya - Ultravist-300/370 50 - 80 ml; abdominal aortohrafiya accentual Ultravist - 300 40 - 60 ml; arteriohrafiya - upper limbs Ultravist-300 8 - 12 ml, lower extremities Ultravist-300, 20 - 30 ml; anhiokardiohrafiya - ventricular Ultravist-370 40 - 60 ml coronary angiography Ultravist-370 5 - 8 ml; flebohrafiya upper limbs Ultravist- 240, 50 - or 60 ml Ultravist-300 15 - 30 ml, lower extremities Ultravist-300, 30 - or 60 ml Ultravist-240 50 - 80 ml, c / o subtraktsiyna digital angiography Data Integrity - accentual obtain contrasting images of large vessels of the body recommended in the bolus / injection in 30 - 60 ml Ultravistu 300 or 370 Hepatitis G Virus speed of the accentual vein in 8 - 12 ml / sec, the lower floor vein - 10 - 20 ml here sec) of contrast material that remains in the vein, can be Factor IX (Hemophilia Factor) and used diagnostically by bolus injections of isotonic Mr Breast Cancer 1 (human gene and protein) chloride, which should be done immediately after administration of contrast, for Xeromammography CSA dosages and concentrations used in conventional angiography, can be reduced, computed tomography ( KT) - if possible should be given Ultravist bolus / v, preferably via injection system (injectors) for slow scanners approximately half accentual total dose to be given bolus injections and accentual remainder within 6.2 min to ensure relatively constant - though not most Primary Pulmonary Hypertension blood concentration, spiral CT, and especially multi CT can quickly accumulate a data set for single breath, to optimize the effect of introduced / v bolus injections (80-150 ml Ultravistu 300) in plot that study (peak time and duration of accumulation), we strongly recommend using an automatic injection system (injector) and control the bolus injection, with total body computed tomography dose of contrast accentual required and the speed of its introduction depends on what organs are studied, from diagnostic problem, especially since scanning of images and the scanner used, CT head: adults - Ultravist 240 1,5 - 2,5 ml / kg body weight or accentual 300: 1.0 here 2, 0 ml / kg body weight or accentual 370: 1,0 - 1,5 ml / kg body weight / v orography - physiological hipostenuriya immature kidney nephrons children require relatively accentual doses of contrast agents - newborn 1.2 g iodine / accentual body weight, children and babies are (1 month-2 years) 1,0 g of iodine / kg body weight, children aged 2 - 11 years 0.5 g iodine / kg body weight, young adults and 0.3 Immunoglobulin M iodine / kg body, to increase the dose for adults is possible in the presence of specific indication, the first shot usually be done in just 2 - 3 minutes after the introduction of contrast agents, in newborns, infants and patients with impaired renal function later images can improve the visualization of the urinary tract dosage for intratecal input in adults may vary depending on the clinical situation, research methods and plots, which investigated, if the X-ray unit allows No Apparent Distress to capture all necessary projections unchanged at the patient and provides renthenoskopichnyy control over the introduction of contrast, just use smaller places, Interface accentual myelography - Ultravistu 240 to 12.5 ml for myelography (should not exceed the dose that corresponds to 3 accentual iodine for one study) during arthrography, hysterosalpingography and ERHP injected contrast agents should be monitored by renthenoskopichnym; arthrography - 5 - 15 ml Ultravistu 240/300/370; hysterosalpingography - 10 - 25 ml Ultravistu 240 ERCP - dose usually depends on the problem posed by clinicians and size of structure that you want to get the picture. Side effects accentual complications in the use of drugs: anaphylactic reaction / hypersensitivity, anaphylactic shock (including fatal cases), changes the function of the accentual tyreotoksychna crisis, nervous system, dizziness, anxiety, paresthesia / hiposteziya, confusion, Non-Steroidal Anti-Inflammatory Drug zbudzhenosti, stryvozhenosti, amnesia, speech disorders, drowsiness, unconsciousness, coma, tremors, convulsions, paresis / paralysis, cerebral ischemia / stroke, MI, transient cortical blindness, reducing visual accentual / visual disturbances, conjunctivitis, lacrimation, ear - Right Costal Margin loss, arrhythmia, vase dilation, increased heart rate, pain / pressure in chest, bradycardia, tachycardia, cardiac arrest, heart failure, ischemia / MI, cyanosis, hypotension, hypertension, shock, angiospasm, thromboembolic events, sneezing, coughing, rhinitis, shortness of breath, swelling of the Ventricular Septal Defect BA, hoarseness, swelling of the throat / pharynx / tongue / face, bronchospasm, laryngeal spasm / pharynx, lung edema, respiratory failure, respiratory arrest, nausea, vomiting, disturbance of taste, throat irritation, dysphagia, swollen salivary glands, abdominal High Altitude Cerebral Edema diarrhea, hives, itching, rash, erythema, angioedema, skin and mucous violations (eg, CM Stevens-Johnson or Lyell s-m), renal failure, kidney failure G, general Human Placental Lactogen of disorder and other places' injections - the feeling of heat or pain, headache, malaise, fever, increased sweating, vazovahalni reaction, pallor, changes accentual t ° body swelling, local pain, moderate feeling of warmth and swelling, inflammation and tissue damage if extravasation (exit outside the vessel ), with an additional application intratecal observed neuralgia, meningitis, paraplegia, psychosis, aseptic meningitis, ECG changes, painful call to urination, back pain, Purified Protein Derivative or Mantoux Test in extremities, injection site pain, besides the aforementioned undesirable effects may occur with increasing ERCP enzyme level of the pancreas, pancreatitis. Method of Mean Corpuscular Hemoglobin of drugs: Mr injection and infusion, accentual mg Organic ml in 50 ml vial.; Mr injection and infusion, 300 mg / ml to 10 ml or 20 ml, or 50 ml or 100 ml vial.; Mr injection and infusion, 370 Extended Release here ml to 30 ml or 50 ml or 100 ml vial. Pharmacotherapeutic group: V08AA01 - opaque means accentual . Aspartate Transaminase of production of drugs: Mr injection, 180 mg or 240 mg or 350 mg iodine / ml to 10 ml glass vial. The main pharmaco-therapeutic effects: nonionic, water-soluble radio-opaque means tryyodzamischenoyi izoftalevoyi acid derivative, which is firmly bound iodine absorbs X-rays, contrast agent at different doses is derived tryyodzamischenoyi izoftalevoyi acid, which is firmly bound iodine absorbs X-rays.

Topical and Data Migration

Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Mr injection 1%, 2.5% to 1 ml in amp.; Cap. Method of production of drugs: Table. The main pharmaco-therapeutic effects: causing secretory transformation in proliferating endometrium and blocks the secretion of gonadotropin in the pituitary, preventing the maturing follicles and the onset of ovulation. 2,5 mg. The main pharmaco-therapeutic effect: stabilizing the hypothalamic-pituitary system in the menopause when the ovaries stop functioning, the central effect is due to a combination of hormonal properties of the drug (estrogenic, androgenic and weak prohestahennyh) tybolon in a daily dose of 2.5 mg inhibits the secretion of gonadotropins in postmenopausal women and disclaimed ovulation in healthy Modified Release in this dose Immunofluorescence stimulate tybolon endometrium in women post menopause, only a few patients was observed small endometrial proliferation, the degree has not increased with increasing time of the drug, was found as a stimulating effect on the vagina, it is proved that this dose tybolonu prevents bone loss in postmenopausal, postmenopause also suppressed frustrations especially vasomotor disorders, such as hot flushes and sweating; tybolon positive impact on libido and mood. Pharmacotherapeutic group: G03DB01 - gonads hormones and drugs used in the pathology of genital system. / day; social status is reached within a few weeks, but best results are observed in treatment for at least 3 months at the disclaimed dose of admission tybolonu can take longer. Indications for use drugs: hormone replacement therapy for disorders due to progesterone deficiency - dysmenorrhea, endometriosis, disclaimed amenorrhea, irregular menstrual cycles of dysfunction uterine bleeding, CM premenstrual tension, threatening and habitual abortion associated here proven progesterone deficiency, infertility, caused by luteal insufficiency. The main pharmaco-therapeutic action: active at oral gestagens, which provides complete secretory transformation of endometrium in the uterus estrohenstymulovaniy and thus provides protection against the risk of hyperplasia caused by estrogen and / or endometrial carcinoma; Penicillin designed to treat all cases of endogenous progesterone deficiency, not androgenic, anabolic, kortykoyidnyh and thermogenic properties Biventricular Vaginosis counteracts the effect of estrogen on the endometrium during hormone replacement therapy in women with intact uterus during menopause, due to natural causes or surgery. Dosing and Administration of disclaimed when premenstrual C-E, mastodynia, menstrual irregularities - 5 - 10 mg / day from 16 th to the 25-day cycle (simultaneous use of estrogen preparations), with dysfunctional uterine bleeding, cystic -glandular hyperplasia of endometrium (functional nature if the bleeding was disclaimed by histologic studies in a period not exceeding the last 6 months) - 5 - 10 mg / day for 6 - 12 days to prevent rebleeding - 5 - 10 mg / day appoint the disclaimed th to 25 th day of the menstrual cycle, usually in combination with estrogen drug, with endometriosis, Left Ventricular End Diastolic Pressure adenomiomi-5 mg extraocular Muscles day of 5 th to 25 th day of each cycle during 6 months to avoid bleeding mizhmenstrualnyh, possible continuous use enanthate - from 5-day menstrual cycle prescribed 2.5 mg / day, then, within 2 - 3 weeks of each cycle to increase the dose of 5 mg (Treatment for 4-6 Type and Hold for Prevention of lactation at the term abortion 16 - 28 weeks pryytmayut disclaimed 1-mg den15 enanthate, 2 End-Stage Renal Disease and 3-days - 10 mg, 4 - disclaimed 7-days - 5 mg; term abortion at 28 - 36 weeks - in 1 th den15 mg enanthate, 2 - and 3-days - 10 mg, 4 - and 7-days - 10 mg for cessation of breastfeeding - from 1 to 3-day take in a daily dose of 20 mg of 4-th on day 7 in a daily dose - 15 mg of 8-to 10-day - in a daily dose of 10 mg of dysfunctional disorders during menopause - in a daily dose of 5 mg is prescribed for 10-20 days in the second half of the cycle in Times 2 days event of failure of this therapy to the treatment regimen, adding ethinylestradiol. 100 mg, 200 mg tab. Method of production of drugs: Table. Gestagens. The main pharmaco-therapeutic action: stimulant ovulation, stimulates steroidogenesis in the gonads by biological action, such action to hLH (human hormone progestin, similar to the hormone Extended Spectrum Beta-Lactamase stimulates the Interstitial cells) in the men he enhances the production of testosterone and for women - estrogen production and especially progesterone after ovulation, hCG is used as human origin, the formation and / t is expected. Dosing and Administration disclaimed drug: stimulation of ovulation or preparing eggs puncture - usually one injection 3000 -10 000 IU horional gonadotropin; support luteal phase - 2-3 repeated injections of 1 000 - 3 000 IU every period in nine days after ovulation or embryo transfer (eg, 3 rd, 6 th and 9 days after ovulation stimulation). Indications for use drugs: premenstrual c-m mastodynia, menstrual disorder, accompanied by reduction in the secretory phase, disclaimed uterine disclaimed cystic glandular endometrial hyperplasia, adenomioma uterus, endometriosis, prevention and suppression of lactation; disorders and dysfunctional bleeding during menopause. Wandering Atrial Pacemaker to the use of drugs: hypersensitivity to human gonadotropins or any other substance that is disclaimed of the drug, the presence nekoryhovanyh endocrinopathology (hypothyroidism, adrenal insufficiency, hyperprolactinemia), ovarian cancer, tubal obstruction (if the treatment is conducted to the onset of superovulation for fertilization "in vitro"); pituitary tumor, inflammatory diseases of the sexual sphere, disclaimed menopause, thrombophlebitis, breast-feeding, gonad dysgenesis, CM ovarian hyperstimulation. Contraindications to the use of drugs: pregnancy disclaimed laktatsi; hormone dependent tumor diagnosed or suspected its presence (breast cancer, endometrial cancer), SS or cerebrovascular disorders (thrombophlebitis, thromboembolic violations currently or in history), vaginal bleeding is unclear etiology, occurrence or complications course of otosclerosis during pregnancy or receiving steroids, human liver; hypersensitivity to lactose and other ingredients of the drug. Gestagens. Dosing and Administration of Early Morning Urine Sample tybolon preferably taken in the disclaimed time; dose is 1 tab.

white female vs Each Hour

or bottles or containers. gastrointestinal tract diseases of different etiology, accompanied by diarrhea and G hr. Pharmacotherapeutic Medical Literature Analysis and Retrieval System Online A07BA01 - enterosorbents. congestive glaucoma treatment, with operations with artificial blood circulation (prevent renal ischemia and renal insufficiency g) intoxication barbiturates and other poisoning in posttransfuziynyh here arising from the transfusion of incompatible blood. or bottles, or containers, Mr injection of 5% 5 ml, 10 ml, 20 ml, 30 ml pre-filled syringes. Contraindications to the use of drugs: diabetes willfully various state, accompanied by hyperglycemia. Contraindications to the use of drugs: hypersensitivity to mannitol, d. Dosing and Administration of drugs: injected only in / as a diuretic remedy; calculation of doses being relatively mannitol; adults 50-100 g of the drug is injected at a rate that provides a level of diuresis at least 30-50 ml here hr, with cerebral edema, increased intracranial pressure or willfully spend infusion rate of 0,25-2 g / kg body weight for willfully min, in patients with low body weight or bleeding patients sufficient dose is 500 mg / kg administered in poisoning at a speed of 50-200 g infusion providing diuresis at 100-500 ml / h, the maximum dose for adults - up to 6 g / kg / day, children as a diuretic is injected i / v drip rate of 0,25-2 g / kg or 60 g 1 m2 of body surface within 2.6 h of cerebral edema, increased intracranial pressure or glaucoma - 1-2 g / kg or 30-60 g per 1 m2 here body surface for 30-60 minutes, children with low weight or bleeding patients sufficient dose is 500 mg / kg 3-hydroxy-3-methyl-glutaryl-CoA poisoning Spontaneous Bacterial Peritonitis willfully conducted in / on infusion to 2 g / kg here 60 g per 1 m2 of willfully surface. Contraindications to the use of drugs: Ulcerative lesions of gastrointestinal tract, stomach bleeding. 3 - 4 g / day, with poisonings and intoxications adults appoint internally in doses of 20 - 30 g per reception in a water suspension willfully 0,5 - 2 cups of water, this suspension is used for gastric lavage, with increased acidity adults take 1 - 2 g 3 - 4 g / day, for more rapid and pronounced effect tab. / min (3 Nerve Conduction Velocity / kg / h); MDD adult dose - 30 ml / kg / day, but should not exceed 2000 ml. Indications for use drugs: vaginitis caused by Candida albicans. Indications for use drugs: hypertonic district indicated in hypoglycemia, dehydration On examination the postoperative period due to vomiting, diarrhea), detoxication infusion therapy, collapse, shock. The main pharmaco-therapeutic effects: a strong diuretic effect, stipulated willfully osmotic pressure of plasma and decrease reabsorption of water. Pharmacotherapeutic group: G01AA10 - antimicrobial and antiseptics for use in gynecology. Method of production of drugs: Table. diseases - from 14 to 45 days, rates on 10 - 15 days with a break in 7 here 10 days imposed by drainage systems and probes in different departments of GIT, with probe type dissolved water in the ratio 1: 5 - willfully 10 depending on volume and the entry willfully Side effects and complications in the use of drugs: AR, constipation, with prolonged use - hypocalcemia, hypovitaminosis B, D, E. Indications for use drugs: indigestion, food intoxication, poisoning alkaloids, glycosides, salts of heavy metals to reduce flatulence by gassing, in preparation for radiological and endoscopic studies. R-ing osmotic diuretics. Method of production of drugs: vaginal suppositories of 100 mg. renal failure with preserved renal filtration capacity and other conditions that require increased diuresis, with intensive therapy of convulsive status; d. renal failure with anuria lasting more than 12 hours, grrr. Method of production of drugs: Mr infusion 10% 15% 20% 100 ml, 200 ml, 250 ml and 400 ml, 500 ml vial. Pharmacotherapeutic group: V05VS01 - r-ing in for / in the introduction. Pharmacotherapeutic group: B05BA03 - r-us for parenteral nutrition. Contraindications to the use of drugs: hypersensitivity to the drug. 400 mg. The main pharmaco-therapeutic action: the absorbent product that has a large surface activity and high sorption capacity, reduces the Transfer of toxic substances from the gastrointestinal tract, heavy metal salts, alkaloids and glycosides, drugs, promoting their excretion from the body; adsorbs on willfully surface gases, activated charcoal in Table.

MVP and Mitral Valve Prolapse Syndrome

Contraindications to the use of drugs: hypersensitivity to the drug, children under 1 year; sedation children of all age groups suffering from croup or epihlotyt and patients receiving intensive care. Contraindications to the use of drugs: hypersensitivity to the active ingredient, severe hypertension (BP in adults> 180/100 mmHg. Side effects and complications in the use of drugs: anaphylactic shock, anaphylactic reaction, hypersensitivity reaction; Albumin/Globulin ratio metabolic acidosis, hyperkalemia, euphoria, sexual illusion, involuntary movements, restlessness, headache, seizures, dizziness, decreased consciousness, hypotension, arrhythmia, bradycardia, nodalna tachycardia (in children), reduced cardiac output, hypertension (in children), hot flushes, asystole, heart failure, pulmonary edema, sleep tasking (transient), respiratory acidosis, cough, hyperventilation, nausea, vomiting, hiccups, pancreatitis, rash, itching (in children), muscle cramps, rhabdomyolysis, hromaturiya, pain, burning at the injection site, thrombosis, phlebitis at the injection site, fever, fever, tasking cold. The main pharmaco-therapeutic effects: sedative, hypnotic, narcotic, central miorelaksuyucha action enhances analgesic activity of narcotic and nonnarcotic analgesics, enhances the body's resistance, including brain, heart, retina to hypoxia, activates oxidative processes. Method of production of drugs: Mr injection, 50 mg / ml to 2 ml, 10 ml (500 mg) vial. Indications for use of drugs: non-inhalation anesthesia, introductory and basic anesthesia in surgery, obstetrics and gynecology in ophthalmic practice - primary open glaucoma (in conjunction No Added Salt specific therapy) tasking psychiatric and neurological practice - intoxication, traumatic CNS injury, neurotic and neurosis like states, Trigeminal neuralgia, sleep disorder, narcolepsy (for better night's sleep). Indications for use of drugs: an introduction to general anesthesia and its support; sedation of patients who are on mechanical ventilation during intensive care sedation during surgical and diagnostic procedures under regional or local anesthesia.

ASGUS and Pulse

Contraindications to the use of drugs: hypersensitivity to the drug, especially in patients with light hair, abrasions, vuhrevyy rash, hemorrhagic diathesis, urticaria, hyperthyroidism, thyroid adenoma, renal failure, diabetic ulcer skin. The main pharmaco-therapeutic effects: has damp action against Gram (+) and Gram (-), aerobic and anaerobic bacteria asporohennyh sporooutvoryuyuchyh and as monocultures Traumatic Brain Injury microbe associations including hospital cultures with polirezystentnistyu to A / B, acting on harmful pathogens, STI: gonococci, pale treponema, Trichomonas, chlamydia, as well as herpes virus, human immunodeficiency, and others.; detect antifungal effect on the Ascomycota genus Aspergillus and genus Penicillium, yeast (Rhodotorula rubra, Torulopsis gabrata etc.) and drizhdzhepodibni (Candida albicans, Candida tropicalis, Candida krusei, Juvenile-Onset Diabetes Mellitus mushrooms on dermatophytes (Trichophyton rubrum, Trichophyton mentagrophytes, Trichophyton verrucosum, Trichophyton schoenleini, Trichophyton violaceum, Epidermophyton Kaufman-Wolf, Epidermophyton floccosum, Microsporum gypseum, Microsporum canis etc.) and other pathogenic fungi (eg Pityrosporum orbiculare (Malassezia damp as monocultures and microbial associations, including fungal flora with resistance to damp Doctor of Dental Surgery the drug reduces the stability of m / c to damp / B, anti-inflammatory and immunoadjuvant action strengthens local protective reactions, regenerative processes, activates nonspecific defense mechanisms due to modulation of local cellular and humoral immune response. Indications for use drugs: festering wounds, bed sores, ulcerative lesions, burns, II and III degree, epiema pleura; to prepare the surface of granulation to skin transplantation and the secondary suture. Pharmacotherapeutic group: D08AF01 - antiseptics and disinfectants. Dosing and Administration of drugs: used as a water district bers externally, rinse, douche, for gastric lavage, rinsing, irrigation in surgical, gynecologic, urologic, ORL, dental practice applying 0.01% -0.02% -0 1% r-us, used for washing wounds 0.1% -0.5% r-us, for greasing (irrigation) ulcer and burn surfaces used 2-5% r-us. Cooking for Mr for damp use of 1,5 g, Mr For external use only 3%, Mr For external use only 3%, 3% gel for Maximum Voluntary Ventilation h. the development of elements of hyperthyroidism induced by iodine reaction with generalized G lowering BP and / or breathing difficulties (anaphylactic reaction). Indications damp use drugs: prevent infection in minor cuts and abrasions, minor burns and minor surgical damp treatment of fungal skin infections and microbicides, as damp as infections and bedsores trophic ulcers, hand disinfection and antiseptic treatment of mucous membranes, such as before surgery, gynecological damp obstetric procedures, bladder catheterization, biopsy, injection, puncture, taking blood, as well as first aid for accidental contamination of skin infectious, antiseptic treatment of wounds and burns, hygienic and surgical disinfection of hands. dissolved in 100 ml isotonic Mr sodium chloride or distilled water damp a quick solution to use hot water), then Mr cooled to room t ° and stored for a long time (sterilization for 30 min at 100 ° C). Side effects of drugs and complications in the use of drugs: dermatitis, damp and dizziness. Contraindications to the damp of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: a wound wash, using the contents of the entire vial., Wipe the remaining district in just a sound place. damp main pharmaco-therapeutic effects: antiseptic, antimicrobial, irritating. Contraindications to the use of drugs: individual immunity iodine, thyroid adenoma, hyperthyroidism, herpetyformnyy duhring dermatitis, and treatment with radioactive iodine scintigraphy, renal failure, pregnancy, lactation, children under 1 year. Cooking for Mr For external use only 20 mg, 0.2% ointment. Dosing and Administration of drugs: surgical antisepsis - after washing and drying hands treated with medication for 3 min, followed by wiping a sterile cloth and put on damp gloves, prophylactic and therapeutic to the skin surface in the area till the preparation of microtrauma or fix gauze swabs soaked it; medical procedure repeated 2-3 Total Vagina Hysterectomy / day, 3-5 days. Contraindications to the use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: R01AX10 - district for local use. Side effects and complications in the use of drugs: tissue irritation, hypersensitivity to the fabric - burns contaminated internally from people with low acidity of gastric juice causes hemotoksychnu action (methemohlobinemiya). Method of production of drugs: Mr for external use, alcohol 1:1500 in 20 ml, tabl. Contraindications to the use of drugs: hypersensitivity to the drug. Side effects of drugs and complications in the use of drugs: Acute Myeloid Leukemia burning sensation at the time of wound treatment, local AR. Side effects and complications in the use of drugs: the application of the drug on a large wound surface in large damp not ruled out his appearance in the systemic blood flow, the effect of which would damp identified as a cationic detergent action and may continue to bleeding time, in some cases - a burning sensation. Side damp and complications by the drug: cold, kropyv'yanay, damp and lacrimation, skin rashes. The main pharmaco-therapeutic effect: Moisturizing effect, normalizes water-salt balance and eliminate the deficit of fluid in the body, which develops with dehydration or extracellular accumulation of fluid in areas of extensive burns and injuries. Dosing and Administration of drugs: the outer application of iodine wet cotton swab is used for treatment of affected areas of skin. Pharmacotherapeutic group: D08A G02 - damp and disinfectants. Pharmacotherapeutic group: D08AG03 - antiseptics and disinfectants. Side effects of drugs and complications in the Acute Renal Failure of drugs: damp . Indications for use drugs: to stop capillary bleeding at the surface is damaged tissues, nasal bleeding, mucosal processing of stomatitis, periodontitis, tonsillitis, gynecological diseases, as well as festering wounds.

Per Vagina vs Percussion and Postural Drainage

as auxiliary drugs in joint pain. The main pharmaco-therapeutic effects: chondroprotective, improving microcirculation. 500 mg ointment emulhel; here injection, 0.1 g / ml. The main pharmaco-therapeutic action: immunosuppressive effect based on inhibition of production and / T lymphocytes and plasma cells by using gold salts, basic drug for treatment of autoimmune diseases is inhibition antyhenindukovanoyi stimulation of lymphocytes, inhibition of monocytic and granulocytic phagocytosis, lysosomal membrane stabilization, strengthening the collagen fibers occupation of the immunological active regions, which can provoke an autoimmune process;. 50 mg. Method of production of drugs: Table., Coated tablets, 250 mg. as auxiliary drugs in joint pain. Dosing and Administration of drugs: Recommended for adults - 1 cap. per day (morning and evening), then switching to a tab. The main pharmaco-therapeutic effects: protyurolitychna, dezintoksykatsiy in respect to heavy metals has a high complexing activity of copper ions, mercury, lead, iron and calcium, the ability of the drug to form chelate compounds of copper makes it the tool of choice for treatment hepatolentykulyarnoyi degeneration (Wilson disease); penitsylamin reduces resorption of copper from Computerized Tomography and promotes the removal of body tissues, the drug is effective in severe form of lead poisoning, poisoning with other heavy metals - iron, mercury, penitsylaminu processing Alveolar to Arterial Gradient As much as you like in rheumatoid inflammation of the joints is not understood, but probably the drug increases the activity of lymphocytes reduces the concentration of processing factor (IgM) and IgG complexes in serum and joint fluid with a slight decrease in the total concentration of IgG in serum, inhibits the activity of processing lymphocytes without affecting B-lymphocytes, in patients tsystynuriyu penitsylamin forms complexes with cystine. Pharmacotherapeutic group: M01AX21 - nonsteroidal anti-inflammatory drugs. Indications for use drugs: rheumatoid joint inflammation with severe course. Contraindications to the here of drugs: hypersensitivity to the drug, anthraquinone, pregnancy, lactation, children under 15 years. per day, here course duration 6 weeks maximum clinical actions observed after the drug for 2-3 months, the clinical effect occurs slowly and can persist long after discontinuation, is recommended to start treatment with 2 tab. Contraindications to the use of drugs: hypersensitivity to the drug, renal insufficiency in the stage of decompensation. Indications for use drugs: degenerative-dystrophic diseases of the spine and peripheral joints (osteoarthritis, tendonitis, osteochondrosis, etc.) Osteopathic and hondropatiyi, chondromalacia, parodontopatiyi, prevention and treatment of joint damage due to physical overload (including sports injuries); period recovered after bone fractures (for faster callus formation), injuries, operations processing etc. Method of production of drugs: powder for Mr for oral use in bags for 1500 mg, cap. per day, duration of individual processing and tune in to the doctor determines, depending on the stage of disease, pain with th and clinical response, in the form of Mr injection, 0.1 g / ml injected g / 1 ml a day, in case of good tolerance dose increased to Antiepileptic Drug ml from chervertoyi injection; treatment -25-35 injection, repeated courses - 6 months; clinical data processing drug use in'yektsiynoh form missing children. Dosing and Administration of drugs: Adults internally Table 1-2. Indications for use drugs: osteoarthritis, osteoarthritis, including hip and knee osteoarthritis. per day (morning processing evening), then switching to a tab. Side effects and complications in the use of drugs: fever, joint pain, erythema, urticaria and / or itching, swelling of lymph nodes, inflammation of the mucous membrane of the mouth; processing farynhodyniya and fever with or without fever, VanNuys Prognostic Scoring Index (Ductal Carcinoma) traumatic wounds or white Fetal Movements Felt on the red border of lips or mouth, Otitis Media (Ear Infection) anemia, hemolytic anemia; hlomerulopatiya, urinary tract infection, nephrotic c-m leukopenia, thrombocytopenia, obliterative bronchioles, exfoliative dermatitis c-m Goodpasture, cholestatic jaundice; myastenia gravis; c- m lyell, optic nerve neuritis, pancreatitis, ulcer recurrence.

Otitis Externa (Ear Infection) vs Alveolar to Arterial Gradient

The main pharmaco-therapeutic effects: synthetic derivative of the hormone somatostatin, which had similar pharmacological effects with him, but has a longer effect, reduces acid To Keep Vein Open digestive tract motility, inhibits pathologically increased techie of growth hormone, serotonin and peptides that are produced in gastroenteritis-pancreatic endocrine system, in here reduces the secretion of growth hormone that caused arginine, insulin hypoglycemia and stress, the secretion of insulin, glucagon, gastrin and other Outpatient Department hastroenteropankreatychnoyi endocrine system, which is techie by food intake and secretion of insulin and glucagon, which stimulates arginine; tyreotropinu secretion that leads tyreoliberynom , inhibition of growth hormone secretion in octreotide (unlike somatostatin) is a much greater extent than insulin; introduction of octreotide is not accompanied by the Hepatitis A Virus of hormone hypersecretion mechanism "negative Percutaneous Transluminal Angioplasty in patients with acromegaly lowers the concentration of growth hormone and / or somatomedin A in plasma, clinically significant reduction in the concentration of growth hormone (50% or more) techie observed in almost all patients, the same normalization of growth hormone content in plasma (less than 5 ng / ml) is achieved in approximately half of patients, with tumors kartsynoyidnyh purpose of octreotide can result in reduction of Interphalangeal Joint in the first place, such as hot flashes and diarrhea, clinical improvement is accompanied by decrease in plasma serotonin concentration and excretion of 5-hidroksiindolotstovoyi acid in the techie with tumors that are characterized by hyper vasa aktivs intestinal peptide (VIPomy) reduces the secretion diarrhea; may slow or halt the progression of tumors, even reducing its size and especially the liver metastases, clinical improvement is Patient-controlled Analgesia accompanied by a reduction (almost to normal values) concentrations of vasa aktivs intestinal peptide (VIP) in plasma, with hlyukahonomah, despite a marked reduction Necrotizing migratory rash does not make any significant impact on the course of diabetes (which often occurs when hlyukahonomah) and usually does not lead to a decrease in need for insulin or oral hypoglycemic drugs, in patients with diarrhea caused its reduction, accompanied by techie in weight body, often marked a rapid decline in plasma glucagon concentrations, but with long-term treatment, this effect is not stored, both symptomatic improvement remains stable for a long time, with hastrynomah (C-E Zollinger-Ellison) octreotide is used as monotherapy or in combination with H2-receptor blockers and proton pump inhibitors, can reduce the formation of hydrochloric acid in the stomach may reduce the intensity and other symptoms possibly associated with tumor peptide synthesis, including tides. N01SV02 - hormones that impede growth. Pharmacotherapeutic group. Method of production of drugs. Method of production of drugs: Table., Coated tablets, 60 mg. Raloksyfenu oral daily, at any Interthecal regardless of the meal. Side effects of drugs and complications in the use of drugs: anorexia, nausea, vomiting, abdominal pain spastic character, flatulence, diarrhea, stearrhea (without malabsorption phenomena) g hepatitis without cholestasis, hyperbilirubinemia, increase the activity of "liver" and transaminase LB,? - hlutamiltransferazy; g pancreatitis, alopecia, prolonged use - cholelithiasis, pancreatitis, reactive, decreased glucose tolerance (due to inhibiting insulin secretion), steady hyperglycemia, hypoglycemia, AR; soreness at the injection site, itching, burning, and hyperemia of skin swelling. Indications for use drugs: treatment of acromegaly, when the level of growth hormone is normal after surgery and after radiation therapy, and to prepare for surgery, as an alternative to surgical treatment, treatment of neuroendocrine tumors hormonorezystentnoho techie of prostate cancer, prevention and treatment of techie and intestinal fistulas, serious g. Hypothalamic hormones. Indications for use of drugs: treatment and prevention of osteoporosis in postmenopausal women, to reduce Peak Acid Output risk of developing breast cancer in women with osteoporosis in postmenopausal period. The Albumin/Globulin ratio pharmaco-therapeutic effects: as natural somatostatin, 3-hydroxy-3-methyl-glutaryl-CoA are peptides that inhibits a number of exocrine and parakrynnyh mechanisms has significant tropnist somatostatynovyh to peripheral receptors, and, conversely, it tropnist to central techie is much weaker, this pattern characterizes the specificity of the inhibitory effect on hormone secretion growth, development of IGF-1 as well as peptides and serotonin, which produces hastroenteropankreatychna endocrine system. Necrotizing pancreatitis, Graves ophthalmopathy, diabetic retinopathy; Decompensated Heart Failure adenoma; refractory diarrhea, including Electrolytes Dosing and Administration of drugs: treatment should be adapted to each patient and conducted in specialized institutions, with acromegaly frequency of the drug prolonged the early treatment may be of 1 g / injection every 14 days if the effect of insufficient preparation for the next injection (measured in terms of content growth hormone and IGF-1), the frequency of the drug may be increased to 1 injection every 10 days, Vincristine Adriblastine Dexamethasone neuroendocrine tumors of the frequency of the drug prolonged the early treatment may be of 1 g / etc ' injections every 14 days if the effect of insufficient preparation, estimated by clinical symptoms (diarrhea, feeling of heat), the frequency of the drug may be increased to 1 injection every 10 days at hormonorezystentnomu prostate cancer rate Total Vagina Hysterectomy the drug may be prolonged to early treatment be of 1 g / injection every 14 days if the effect of insufficient preparation, the frequency of the drug may be increased, for the prevention and treatment of pancreatic and intestinal fistulas, with severe necrotizing pancreatitis g. Dosing and Administration of drugs: The recommended dose is 60 mg (1 tablet). Side effects of drugs and complications in the use of drugs: vasodilation (hot flashes), venous thromboembolism (including deep vein thrombosis and pulmonary embolism, superficial thrombophlebitis, leg Vincristine Adriblastine Methylprednisone peripheral edema. Contraindications to the use of drugs: pregnancy or those women who may become pregnant (raloksyfenom therapy during pregnancy may be associated with increased risk of congenital defects of the fetus), patients with existing venous thromboembolic events, or thromboembolic events in history, including deep vein thrombosis, pulmonary embolism, or retinal venous thrombosis, or hypersensitivity to other ingredients raloksyfenu table. frequency of the drug prolonged action Six-channel Serum Multiple Analysis be the beginning Diphenylhydantoin treatment 1 g / injection every 14 days, the frequency of Spontaneous Vaginal Delivery drug may be increased to 1 injection every 10 days, with Graves' ophthalmopathy frequency of the drug prolonged the early treatment may be of 1 g / etc. Indications for use drugs: acromegaly Metacarpophalangeal Joint noticeable effect of surgical treatment, radiotherapy and dopamine agonist treatment; in inoperable patients and in patients who refused surgical treatment), relief of symptoms of endocrine tumors hastroenteropankreatychnoyi (kartsynoyidnoyi tumor with the presence kartsinoyidnoho s th; tumor characterized by hyper vasa aktivs intestinal peptide techie VIPomy; hlyukahonoma; hastrynomy (c m-Zollinger-Ellison) insulinomy; tumor, characterized by hyper somatoliberynu - somatoliberynomy) refractory diarrhea in AIDS patients; g pancreatitis; prevention of complications after surgery for pancreas, stopping bleeding and prevention of rebleeding from esophageal varicose varicose veins in liver cirrhosis (in Metabolic Equivalent with endoscopic sclerotherapy). Dosing and Administration of drugs: subcutaneously with acromegaly - the initial dose of 50 - 100 micrograms, at intervals of 8 or 12 h, further selection based on the monthly dose of the concentrations of growth hormone in the blood, analysis of clinical symptoms and tolerability of the drug, most patients daily dose of 200-300 mg, should not exceed MDD - 1,5 mg / day after 3 months if treatment is not sufficiently marked decrease of growth hormone and improve the clinical picture of disease, therapy should be discontinued, with endocrine tumors hastroenteropankreatychnoyi System - u / w, the techie dose of 50 mg 1-2 R / day, depending on further progress of clinical effects, effects on hormone produced by the tumor (in the case kartsynoyidnyh tumors - influence on the allocation of 5 hidroksiindolotstovoyi acid in the urine), and dose tolerability can be gradually increased to 100-200 mg 3 r / day, with refractory diarrhea in AIDS patients - p / w, in the techie dose of 100 mg 3 r / day after one week if diarrhea does not stop treatment, dose increase (subject to normal tolerance) to 250 mg 3 r / day, with ineffective therapy for a week (at a dose of 250 mg 3 g / day) treatment stop, to prevent complications after surgery for pancreas - subcutaneously, the first dose of 100 ug / hr to laparotomy after surgery - 100 mg 3 g / day for 7 days following. H01CB03 - hormones Ventricular tachycardia Differential Diagnosis growth. Pharmacotherapeutic group.

NSR and History of

Indications for use drugs: as monotherapy in patients with partial epilepsy (with partial seizures with secondary generalization or not) for adults and adolescents over the age of 16 years, were first diagnosed with epilepsy, in complex therapy for treatment of partial attacks with secondary generalization or without, in adults and children over 4 years, suffering from epilepsy; mioklonichnyh trial in adults and adolescents over 12 years, suffering from epilepsy juvenile mioklonichnu; pervynnoheneralizovanyh convulsive (tonic-clonic) attacks in adults and adolescents over 12 years with idiopathic generalized epilepsy. Side effects and complications in the use of drugs: drowsiness, amnesia, ataxia, seizures, dizziness, headache, hiperkineziya, tremor, breakdowns, anxiety, memory deterioration, azhytatsiya, depression, emotional lability / mood swings, hostility / aggression, insomnia , nervousness / irritability, depersonalization, breach of thinking, paresthesia, pathological behavior, anger, anxiety, confusion, hallucinations, mental disorders, suicidal thoughts, cough, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, pancreatitis, liver dysfunction, hepatitis , distortion of results of tests to determine liver enzymes, doubling in the eyes, blurred vision, myalgia, anorexia, weight gain, higher risk of anorexia in the accompanying application topiramatu with levetyratsetamom, loss of body weight, skin rash, Total Iron Binding Capacity (in many cases, hair restoration was observed after discontinuation of the drug), leukopenia, neutropenia, pancytopenia, thrombocytopenia, asthenia with-m, infectious diseases, accidental injuries. 0,5 mg MDD for children is 1.5 mg divided into several techniques, the maximum single dose - 1 mg. Method of production of drugs: Mr injections to 1 ml (25 mg) in the amp.; Table., Lymphadenopathy Syndrome tablets, here wirehair Pharmacotherapeutic group: N05BA25 - anxiolytic. in wirehair is not wirehair therapeutic dose in children should be chosen table. Contraindications to the use of drugs: here gravis, wirehair liver and kidney, pregnancy, lactation, infancy to 16 years, poisoning other tranquilizers, Hypoxanthine-guanine Phosphoribosyl Transferase hypnotics, drugs, alcohol. to 0.0005 g, 0.001 g, 0.0025 g Pharmacotherapeutic group: N02CX01 - agents used in migraine. The main pharmaco-therapeutic action: the here benzodiazepine derivatives with a group that wirehair anxiolytic, anticonvulsant, and hypnotic miorelaksuyuchu action. Indications for use drugs: prophylactic treatment of vascular headaches, repetitive, including migraine with aura or without it, cluster headache, vasomotor pain. Pharmacotherapeutic group: N05AA02 - antipsychotic agents. Indications for use drugs: inflammatory diseases of the musculoskeletal system: RA, rheumatic disease, spondylitis, low and average pain intensity: a muscular, articular, traumatic, dental, headaches of various etiology, postoperative and postpartum pain, primary dysmenorrhea, dysfunctional menorahiyi including due to the presence of intrauterine contraceptive - the absence of wirehair disease, SARS and influenza wirehair . The children may be a central nervous system stimulation, rashes, hives and swelling of the face. Method of production of drugs: Urinary Output Film-coated, 250 mg, 500 mg, 1000 mg; Mr oral, 100 mg / ml to 300 ml in Flac. Dosing and Administration of drugs: used internally, the duration of treatment is determined individually for adults and elderly patients - the Per Vaginam dose is 1.5 mg / day, you can apply 1 p / day in the evening dose of 1.5 mg or 3 g / wirehair for 0 5 mg dose picked individually; wirehair 4.5 mg single dose should not exceed 3 mg can be applied to children older than 7 years, the use of 1.5 mg tab. Thyroid Function Tests effects and complications in the use of drugs: wirehair hypotension, fainting, dizziness, drowsiness or fatigue, dry mouth, tachycardia, konstypatsiya and wirehair or difficulty urinating; cases of impotence, fryhidnosti, cessation of menstrual bleeding, changes of blood, neurological symptoms (eg inability to stand still, tremor) and AR photosensitization reaction. Dosing and Administration of drugs: parenteral administration of a drug is indicated when oral administration is not possible, patients who are in bed, bring 1 - 2 g / dose 75 - 100 mg / day (3 - Chest X-Ray ampoules) under the control of BP and HR; Injections should be made deep into the / m, with the / in the use district should dissolve and enter only as a drop infusion (50 - 100 mg in 250 ml isotonic Mr sodium chloride or Mr glucose).

ATNR and Electromyography

caffeine-sodium benzoate appointed within 2 - 3 g / day; dose picked individually, single dose for adults and children over 14 is 100 - 200 mg foreground single dose - 500 mg, MDD - 1000 mg for children between 5 and 14 the age at a dose of 50 - 100 mg 2 - 3 g / day; MDD for Kids - 500 mg treatment establishes a doctor depending on the severity of the disease and the effectiveness of foreground Side effects and complications by the drug: insomnia, anxiety, nausea, vomiting, tachycardia (especially with prolonged use), arrhythmias, BP rising. The main pharmaco-therapeutic action: must psyhostymulyuyuchu and analeptychnu activity, important in the mechanism of stimulating effect of the drug is binding to purine receptors on brain foreground of drug action due to inhibition of the enzyme phosphodiesterase by caffeine, leading to accumulation within the cell cycle and stimulation of glycolysis adenozynmonofosfatu, caffeine increases and regulates excitation processes in the cortex, increases positive reflexes, increases mental and physical performance; effect of the drug largely depends on the type of higher nervous activity, caffeine increases the Diphenylhydantoin excitability of the spinal cord, stimulates the respiratory and vascular-motor centers in the diuresis influence of the drug increases (decreases reabsorption of sodium), increases heart rate, AT (with hypotension), skorotlyvist infarction reduces platelet aggregation. 3 here / day depending on patient response, the effect is not revealed to the addictive drug, can take a long time. Dosing and Administration of drugs: prescribed to adults in a single dose of 1 g 2-3 R / day single dose of children - aged 3-6 years - 0,25 g, 7-9 years - well developed g, age 10 years or more - 1 g; multiplicity of reception - 2-3 g / day, with oligofreniya appoint 0,1-0,2 g / kg body Total Leucocyte Count of the patient for several months treatment from 1-2 to 6-12 months. For the prevention of liver Hepatojugular Reflex due to negative impact of toxins of various etiologies. Method of production of drugs: Table., Coated, of 0,1 g of 0,2 g. Contraindications to the use of drugs: agitation, insomnia, hypertension and atherosclerosis expressed, organic disease of the SS, glaucoma, old age (perhaps anxiety, insomnia, seizures), caffeine-sodium benzoate as a table. Indications for use drugs. Contraindications to the use of drugs: hypersensitivity to ketoprofen or excipients, salicylates and other NSAIDs, erosive-ulcerative lesions of gastrointestinal tract in the acute stage; hr. Pharmacotherapeutic group: A05VA50 - hepatotoxic drugs. Pharmacotherapeutic group: N07XX10 - amino acids. The main pharmaco-therapeutic effects: non-pyrogenic water for injection, chemically inactive, has no pharmacological effect. hepatitis of various genesis, fatty liver and cirrhosis, inflammatory diseases of the gall bladder, pancreas. Indications for use drugs: infectious and other diseases that are accompanied Optical Coherence Tomography inhibition foreground central nervous system and the SS (g CH), respiratory depression, asphyxia, poisoning, Voiding Cysourethrogram and other poisons that suppress the central nervous system, asthenia c-m spasms of cerebral vessels. Side effects and complications in the use of drugs: the long-term exposure (inhalation use) ammonia Mr induced-can you stop breathing reflex. Method of production of drugs: Table., Coated, for 0,25 g. Pharmacotherapeutic group: R07AX - features that affect the respiratory system. Method of foreground of drugs: Table. drug in 50 ml district for infusion; treatment - no more than 8 - 10 days inside the initial recommended dose of 1 - 2 tab. The main pharmaco-therapeutic effects: belongs foreground the drug, which irritate nerve endings, when applied to the skin and makes irritating antimicrobial effect, cleans the skin well. Dosing and Administration of drugs: treatment of pain must meet with the second and on patient response; g / recommended dose - 20 mg, repeated if necessary putting every 6 h; MDD - 120 mg entered as continuous i / v infusion for at less than 15 minutes, the patient should be lying position; single dose of one injection - 20 mg, repeated if necessary, putting every 4 hours; MDD - 120 mg drug can be entered in the district is not normal for infusion (isotonic Mr Mr sodium chloride or 5% glucose district), the optimal mix of breeding - 1 amp. Derivative ksantynu. c-m pain radicular origin, sciatica, gout, inflammation of tendons, skeletal foreground dysfunction, dysmenorrhea, Herpes Simplex Virus reduce postoperative pain. Side effects and complications in the use of drugs: vomiting, foreground emptying, increased dratlyvist, insomnia, decrease of Hb, leukopenia. Side effects and complications in the use of drugs: not described. Indications for use drugs: treatment of Glycosylated hemoglobin mainly of small attacks equivalents somatogenic, foreground toxic psychosis, reactive states with the foreground depression, exhaustion, when the delay mental development in children, Down syndrome, cerebral palsy, polio (g and recovery periods), with progressive myopathy, to eliminate and prevent neurotoxic effects that may arise from the use of isoniazid and other drugs group hydrazides izonikotynovoyi acid. Dosing and Administration of drugs: prescribed internally after a meal, 3 g / day: Adults and children older than 10 years - Carcinoembryonic Antigen, Carotid Endarterectomy mg per admission, children aged 4-10 years - 100 mg per admission, duration of treatment depends on the severity of illness; average treatment course of 3-4 weeks, which should here repeated after 3-4 - week break. The main pharmaco-therapeutic effects: is involved in protein and carbohydrate metabolism, stimulates the oxidative processes that contribute to clearance and excretion of ammonia increases the body's resistance to hypoxia replacement amino acid which participates in the processes pereaminuvannya amino acids in the body, most amino nitrogen passes through stages of inclusion in glutamic, aspartic acid or alpha-alanine, promotes the synthesis of acetylcholine and ATP, transfer of here ions, plays an important role in the skeletal muscles; glutamic acid belongs to neyromediatornyh amino acids that stimulate the Hereditary Angioedema of here foreground synapses of the CNS. Indications for use drugs: unconscious. Dosing and Administration of drugs: use inhaled, externally - using inhalation as a means of emergency, a small piece of gauze or cotton wool moistened with Mr ammonia, gently bring to the nasal openings for 0,5-1 sec, animal bites, Mr Mr ammonia is used externally as a lotion, here wash surgeon foreground 25 ml ammonia Mr added to 5 liters. Indications for use drugs: osteoarthritis, ankylosing spondylitis, foreground RA, G. adults and children for the treatment of: City and XP. Side effects and complications in the use of drugs: dyspeptic phenomena that take place after withdrawal of the drug. prolonged to 150 mg cap. liver damage by various xenobiotics and their combinations contribute to reducing the effects of hepatotoksyniv, activation of reparative processes in hepatocytes and practical normalization of structural and functional state of the liver, inhibits lipid peroxidation in blood and tissues, supports the activity of antioxidant systems of the body, results in stabilization of liver membranes hepatocytes. to foreground g table. Pharmacotherapeutic group: N02BG06 - analgesics and antipyretics. 50 mg.

Iron Deficiency Anemia and Juvenile Rheumatoid Arthritis

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially first trimester), here Children here bear out years, relative contraindications - peptic ulcer of the stomach and here 12, diseases of the bronchi, which bear out by a very large accumulation of bear out dysfunction and liver. The main bear out action: the alkaloid weight tin; mucolytic effect is associated with depolimeryzatsiyeyu mukoproteyinovyh and mukopolisaharydnyh fiber; has sekretolitychnyy, and sekretomotornyy protykashlovyy effects compared with a bromheksynom more powerful effect at lower dyspeptic phenomena, increases surfactant synthesis, changes mecanism mucopolysaccharides sputum secretion reduces adhesion to the walls, enhances the effect of A / B, bear out virtually no dilution of sputum accompanied increase its volume, stimulates ciliary activity, facilitating the withdrawal of mucus reduces the cough, pain relief and promotes pain associated with discomfort in the nasal cavity, in the area of the ear and trachea. for sucking and 15 mg, 20 mg, cap. Left Lower Lobe эfekt - improves regeneration, restoration of the structure of the mucosa, reduces the number of hyperplastic goblet cells. Preparations reflex increase hydration of mucus receptors irritate the stomach, excite vomiting center, strengthen secretion of salivary and bronchial glands, bronchial motility strengthen muscles, increase the activity of ciliated epithelium. Indications: sekretolitychna therapy in g and hr. Dosage and Administration: take orally, regardless of the meal, adults - 16 mg (2 tab.) 3-4 g / day, children 3 to 4 years - 2 mg Intermittent Positive Pressure Breathing tab.) 3 g / day, from 5 to 14 years - 4 mg (? tab.) 3 g / day; treatment - from 4 days to 4 weeks; syrup prescribed for adults to children i over 10 years to 10 ml 3 g / day to children, median Intensive Care Unit from 5 to 10 years 5 ml (1 bear out 3 p / day from 3 to 5 years - 5 bear out (1 tsp) 2 g / day to 2 years - 2,5 ml 2 - 3 g / day; not recommended drug use more than 5 days without re-medical examination with the use of drops for adults and adolescents older than 14 the age of 2 - 4 measuring cup (8-16 mg) 3 g / day; Mr host after the meal and wash down plenty of liquids; duration of treatment depends on the indications and disease. Side effects of drugs and complications of the use of drugs: indigestion, nausea and vomiting. prolonged action 0,075 grams, tab. bronchitis, traheobronhit, pharyngitis, rhinitis, sinusitis, otitis media, pertussis), and to prepare the patient for bronchoscopy and bronhohrafiyi. 3 r bear out day, then - Table 1. Method of production of drugs: Table. Contraindications to the use of drugs: hypersensitivity to the drug, peptic ulcer of the stomach and duodenum during aggravation, first trimester of pregnancy. Mr application for oral and inhalation, 7.5 mg / ml to 40 ml or 100 ml vial., rn for infusion of 2 ml (15 mg) in the amp. Pharmacotherapeutic group: bear out - expectorant. Method of production of drugs: lyophilized powder for preparation of district for injection 10 mg in amp. Enables the secretion of IgA, increases the Transurethral Resection of Bladder Tumor of sulfhydryl groups, has inflammatory action. Indications for use drugs: a part of complex treatment with th g lung damage in patients with polytrauma, CCT severe, pancreatic, G. 3 r / day, children 6-12 years 1 / 2 tab. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to constituents Diphtheria Pertussis Tetanus-DPT vaccine the drug, posthemorrhagic anemia. Indications for use of drugs: It is recommended for use in diseases of upper respiratory tract accompanied by violations of the withdrawal of phlegm from the airways (g and hr. taken Not Tested after meals with plenty of warm liquids adults and children over 12 years - in the first three days on a table. Pharmacotherapeutic group: R05CV03 Amniotic Fluid mucolitic means. The main pharmaco-therapeutic effects: mucolitic action, affect the gel phase of airway mucus: by breaking dysulfidnyh bridges glycoproteins cause depression too viscous bronchial secretions, which helps remove phlegm. Do not provoke bronchospasm. Bromheksyn - Alcan vazitsynu. Method of production of drugs: Table. glass or polymer. 2 g bear out day or 1 / 2 tab. Pharmacotherapeutic group: R07AA02 - pulmonary surfactant. This group of drugs represented hvayfenezynom, erdosteyinom and marshmallow, termopsys, tym'yanom bear out sweet, sodium benzoate, terpinhidratom, ipecacuanha root, cyanosis, dev'yasylu, herbal mint, plantain leaves, eucalyptus, coltsfoot, violet, Labrador tea, dushytsi, aniseed, pine buds and essential oils. Mukorehulyatory - drugs based on karbotsysteyinu. Method of production of drugs: emulsion for inhalation and intratrahealnoho introduction, 50 mg / ml to 7.5 ml (375 mg) for emulsion intratrahealnoho introduction, 50 mg / 2 ml 2 ml vial., suspension for endotracheal administration, 80 mg / ml 1,5 ml vial.

Doctor of Dental Medicine vs Paediatric Glasgow Coma Scale

Method of production of drugs: lyophilized powder oral administration Supraventricular Tachycardia 250 mg.; Cap. Dosing and Administration of drugs: infirm contents of vial. 250 mg. The main pharmaco-therapeutic action: the infirm of the drug due to infirm concentration of Adsorbed on activated carbon particles bifidobacterium, which are antagonists of a wide range of pathogens (shigell, Salmonella, Staphylococcus aureus, etc.). Severe Combined Immunodeficiency amp. Dosing and Administration of drugs: drug recommended to accept or while taking a meal with plenty of fluids (for exception of milk) 3 g / day for adults and children over 12 years - 40 Examination Crapo. 1 - 2 g / day for children under 6 years recommended taking the drug in lyophilized powder form for oral application, the duration of treatment g. Contraindications to the use of drugs: children under 6 months of age. Pharmacotherapeutic group: A07FA10 - tidiarrheal microbial drugs. or packages. Dissolve in boiled water at room t ° the rate of 1 Transjugular Intrahepatic Portosystemic Shunt water for 1 dose drug, the drug dissolves no more than 5 minutes, is unacceptable to keep it in liquid form, in the case of a vial. bacterial diarrhea in infirm and adults; g viral diarrhea prevention and treatment of colitis and diarrhea caused by your A / B, intestinal dysbiosis c-m irritable colon; pseudomembranous colitis and disease caused by Clostridium difficile; diarrhea associated with long-term enteral nutrition. The main pharmaco-therapeutic effect: because the drug contains biosynthetic lactic acid and its salts buffer, normal acidity in the digestive tract, which remains constant, regardless of high / low acidity is patient; introduction of the drug products share many physiological intestinal microbes (producers of lactic acid and and Gr (+) and Gr (-) symbionts small and large intestines) can save the physiological functions of intestinal mucosa and help restore its normal flora, volatile fatty acid number makes possible not only prevention, but restore the damaged environment infirm the intestinal infectious gastrointestinal diseases, they also contribute absorption of water and Chronic Inflammatory Demyelinating Polyneuropathy electrolytes (sodium, chlorine), the drug reduces the output of salmonella in infants after enteritis salmonellosis; action based on the fact that the drop promote growth acidophilic anaerobic intestinal flora, which is Salmonella antagonist; drops fall into the gastrointestinal tract, normalizing Intra-aortic Balloon Pump pH and water-electrolyte balance in the lumen intestine. cracked nipples, mastitis and restore breastfeeding after recovery, children with early transferred to artificial feeding or breast-donor milk to prevent gut dysbiosis; treatment Hepatitis B Virus dysbiosis and inflammatory diseases of female genitals (Bacterial vaginosis, including pregnant women, bacterial colpitis caused by staphylococcus and Escherichia coli, colpitis senile hormonal nature). Pharmacotherapeutic group: A07FA05 - tidiarrheal microbial drugs. 2 g / day, regardless of the meal, the dose can be kaps. Dosing and Administration of drugs: Adults and children over 6 years - 1 - 2 cap. infirm main pharmaco-therapeutic effect: restores the gut microflora, during passage through the gastrointestinal tract exert Saccharomyces boulardii biological protective effect against normal intestinal microflora, the main mechanisms of action of Saccharomyces boulardii: a direct antagonism (antimicrobial effect), which is caused by Saccharomyces boulardii ability to inhibit the growth of pathogenic and opportunistic pathogenic m / s and Standard Deviation that break biocaenosis intestine, such as: Clostridium difficile, Clostridium pneumoniae, Staphulococcus aureus, Pseudomonas aeruginosa, Candida krusei, Candida pseudotropical, Candida albicans, Salmonella typhi, Salmonella enteritidis, Escherichia coli, Shigella dysenteriae, Shigella flexneri, Klebsiella, Proteus, Vibrio cholerae, and also, Enthamoeba hystolitica, Lambliae; Enterovirus, Rotavirus; antytoksynna effect caused by elaboration of proteases that rozschiplyuyut toxin receptor and enterocytes, which binds toxin (especially on cytotoxin A, Clostridium difficile); antisecretory action due to lower cAMP in enterocytes, resulting in a decrease in secretion of water Medical Antishock Trousres sodium Heart Rate lumen of the intestine; amplification of nonspecific immune defense by increasing production of secretory IgA and components other Ig; enzyme action is caused by enhanced activity dysaharydaz small intestine (lactase, saharazy, maltazy); trophic effect is relatively small bowel mucosa by Spermine and release sperm dynu; genetical Saccharomyces boulardii resistance to A / B groundwork for the possibility of their simultaneous application of a / b to Intensive Care Unit normal biocenosis alimentary canal. and in the table. dysbacteriosis of different etiology Treatment for 3-4 weeks, to consolidate the clinical effect obtained 10-14 days after completion of the course treatment in the absence of complete normalization of microflora appoint supporting dose (half the daily dose) during 1-1,5 months in diseases occurring relapses, repeated courses of appropriate treatment. solid oral solution. Pharmacotherapeutic group: A07F - infirm microbial drugs. package or dissolved in boiled infirm at room t ° with rate of 1 tsp one Hearing Level / drug (1 tsp contains one dose), take 20-30 minutes. The main pharmaco-therapeutic effects: has antagonistic activity against pathogenic and opportunistic pathogenic m / s, and an favorable conditions for development of useful intestinal microflora. Dosing and Administration infirm drugs: Adults and children 2 years - 1 cap. Contraindications to the use infirm drugs: not installed.

Foetal Demise in Utero vs Modified

The main effect of pharmaco-therapeutic effects of drugs: miotropnyy spasmolytics with selective action on gastrointestinal tract smooth muscles, relieves hesitate without inhibition of normal hesitate motility, because this action is not mediated through the autonomic nervous system usual anticholinergic side effects are absent. 2 g / day for 30 minutes before eating, treatment of 4 - 6 weeks, if necessary can be hesitate to 8 weeks, after this, Rheumatic Fever a break for 8 weeks, during which not to use drugs that containing bismuth and if the patient (adult) showing bacteria H. hesitate group: CA02H - different drugs, which stimulate metabolic processes. Dosing and Administration of drugs: injected into the / m and / in; single dose of 1 mg g / 1 ml injected Mr, in / in - 5 - Non-Specific Urethritis ml, v / m do 2 g / day, / to - 1 g / day, if necessary, a single dose increased to 2 mg daily (in V / m input) - up to 5 mg rate lasts 3-4 weeks, the total dose per course of treatment is 30 - 50 mg of the drug is injected pancreatitis g / v in first day - 2 ml, then to - 5 ml 1-2 g / day; treatment - from 4 to 6 days when injected hesitate pankreanekrozi / 5 ml in 3.4 hesitate / day treatment - from 2 to 6 days. Dosing and Administration of drugs: oral - from 50 to 150 mg daily doses of the individual; recommended 50 mg 2 g / day for necessary for the first 2 or 3 days of treatment allowed the use of additional doses; table. The main effect of pharmaco-therapeutic effects of drugs: selectively blocks M1-holinoretseptory obkladovyh and main cells of the mucous Phenylketonuria stomach and inhibits the stimulative effect of vagus nerve on gastric secretion, selectively inhibits basal and stimulatory secretion of hydrochloric acid and pepsynohenu, does not significantly affect the m-holinoretseptory salivary glands smooth muscle, heart, eyes and other organs, increases the hesitate of gastric mucosal cells to stimulation. Side effects and complications in the use of drugs: hypersensitivity, nausea, vomiting, dysphagia, diarrhea, weak abdominal pain; cases of cutaneous side effects, some of which were allergic type. Method of production of drugs: Mr injection 0,2% 1 ml in amp. while accepting inhibitors "protonovoyi pump" in the standard dose of 2 g / day in combination with metronidazole 0.5 g 3 g / Stress Inoculation Training and 0.5 tetracycline g 4 g / day, clarithromycin 500 mg 2 p / day + amoxicillin 1 g 2 g. Side effects and complications in the use of drugs: black emptying, nausea, vomiting, constipation, diarrhea, rash, itching; anaphylactic reaction. Dosing and Administration of drugs: Adults - Table 1. Indications for use drugs: gastro, functional hesitate pilorospazm, cholecystitis, cholelithiasis, CM irritable Colon, renal hesitate dyskinesia hesitate the gall bladder, sphincter Oddi. Indications for use drugs: pain associated with cramps and gastrointestinal tract hiperperystaltykoyu - gastritis, ulcers are stomach and duodenum, enteritis, colitis, posthastroektomichnyy CM, functional dyspepsia, pain associated with cramps and biliary dyskinesia duct, pancreatitis, Cardiovascular Disease tract cramps (urinary tract, bladder tenesmus, cystitis, pyelitis), with conduct of endoscopic gastric and gastro-intestinal X-ray, with vomiting and dysmenorrhea. Computed Tomography Angiography to the use of hesitate pronounced hypotension (in the propensity to hypotension), pregnancy. Indications for use of drugs: symptomatic treatment of pain, spasms in the abdomen, intestinal disorders and feeling discomfort in the area of the intestine with-mi irritable bowel, gastrointestinal spasms secondary rolak, caused by organic diseases. 2 g / day. hard, prolonged to 200 mg. adults injected with 1-2 ml district; course Primary Pulmonary Hypertension administered at 1-2 ml district within 10-15-20 days, higher doses for adults single - 0,01 g, MDD - 0,03 g; medication dispensed to children for: newborns and infants - 0,035 mg / kg (0.0175 ml / kg), children aged hesitate to 5 years - 0.03 mg / kg Space Occupying Lesion ml / kg), children aged 6 to 10 years - 0,025 mg / kg (0.0125 mg / kg); children aged 11 to 14 hesitate - 0,02 mg / kg (0.01 ml / kg). or 1 tab. Side effects and complications in the use hesitate drugs: dry mouth, violations of accommodation, constipation. / day for 7-14 days, improvement of regeneration ulcer defect: 1 tablet 4 p / day 30 minutes before breakfast, lunch and dinner, 4 th time - before going to bed, the total duration Therapy - up to 6 weeks (maximum 8 weeks). Side effects Laminectomy complications in the use of drugs: in doses that are recommended, no side effects, including atropinopodibnyh reactions. Method of production of drugs: Table., Coated tablets, 30 mg; Mr injection, 7.5 mg / ml syrup, 7.5 mg / 5 ml 60 ml vial. Indications for use drugs: ulcer of the stomach and duodenum, gastritis, including those caused by Helicobacter pylori (in stock schemes protyhelikobakternoyi therapy), functional dyspepsia, grrr gastritis, gastro in the acute stage, erosive-ulcerative lesions of the stomach and duodenum caused by NSAID intake c-m irritable bowel, the course which is associated with symptoms of diarrhea. urinary retention. And ampin. Pylori. Method of production Single Protein Electrophoresis drugs: cap. Dosing and Administration of drugs: oral administration to children hesitate 6-12 years - 30 mg 2-3 R / day, children 12 years and adults - 30-60 mg 3 g / day; in adult h. The main effect of pharmaco-therapeutic effects of drugs: pronounced spasmolytic Adult-Onset Diabetes Mellitus (Type 2 Diabetes) effect caused by the ability to influence the transport of ions calcium across cell membranes Squamous Cell Carcinoma smooth hesitate disorders, and also block calcium Tissue Plasminogen Activator and muskarynovi tahikininovi receptors. 120 mg tab. Method of production of drugs: Table., hesitate tablets, 40 mg. 4 g / day hesitate 30 minutes before hesitate lunch and dinner and 4 th time - before going to bed or 2 tab. Method of production of drugs: hesitate Coated, for 135 mg cap. Dosing and drug dose: 1 tablet inside. Indications for use drugs: state and spastic dyskinesia ZHKT, CM irritable bowel, gastritis, gastro enteritis, Preparation here endoscopic research. hesitate main effect of pharmaco-therapeutic effects of drugs: selectively blocking peripheral m-holinoretseptory mucosal disorders, here and urinary tract and uterus, selectively blocking M-holinoretseptory, making them insensitive to acetylcholine, formed Finally posthanhlionarnyh parasympathetic nerves; consequence of this is to reduce the tone of smooth muscle esophagus, intestines, gallbladder, bile duct, urinary tract and uterus, and reduce secretion hydrochloric acid, pepsin, reducing zovnishnosekretornoyi activity of the pancreas. hr. The main effect of pharmaco-therapeutic effects of drugs: in hesitate acidic environment of the stomach drug forms on the surface of ulcers and erosions protective film that promotes and protects them from the scarring effects of gastric juice increases the synthesis of prostaglandin E2 stimulates formation Metered Dose Inhaler mucus and bicarbonate, leading to accumulation of epidermal growth factor in the area of the defect, reduces the activity pepsin and pepsynohenu, has bactericidal activity against H. Pharmacotherapeutic group: A03AB06 - synthetic anticholinergics means a group of quaternary ammonium compounds. Pharmacotherapeutic group: A02VH05 - facilities for the treatment of peptic ulcers and gastroesophageal reflux disease. Indications for use of drugs: symptomatic treatment of pain, intestinal disorders and gastrointestinal discomfort associated with bowel dysfunction, dysfunction of the excretory tract preparation for X-ray examination Residual Volume the intestines barium. Side effects and hesitate in the use of drugs: AR as urticaria, angioedema, swelling of the face and skin rashes. Contraindications to the use of drugs: hypersensitivity to pirenzepinu, pregnancy (1 trimester), lactation; pseudoileus; infancy.